Skip to main content
. 2020 Feb 3;12(2):126. doi: 10.3390/pharmaceutics12020126

Figure 5.

Figure 5

In vitro accumulate drug release percentage versus time of CAT3, OA-CAT3-SLN, and CAT3-SLN (A), Higuchi model of CAT3 suspension release (B), zero-order with the F0 model of OA-CAT3-SLN release (C), and Weibull model of CAT3-SLN release (D).